Skip to main content
Log in

Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney

  • Brief Report
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Parvalbumin is a cytosolic calcium-binding protein expressed in the distal convoluted tubule of the renal nephron. Among epithelial renal tumors, the reactivity for parvalbumin is observed in chromophobe renal cell carcinomas and frequently in oncocytomas. On the other hand, there are no data available on parvalbumin expression in the mesenchymal tumors of the kidney. Therefore, the purpose of this study was to evaluate the expression of parvalbumin in the spectrum of PEC (perivascular epithelioid cells) lesions of the kidney. Sixty-six PEC lesions (37 classic angiomyolipomas, 10 microscopic angiomyolipomas, 7 epithelioid angiomyolipomas/pure epithelioid PEComas, 5 leiomyoma-like angiomyolipomas, 3 lipoma-like angiomyolipomas, 2 intraglomerular lesions, 1 angiomyolipoma with epithelial cysts (AMLEC), and 1 sclerosing angiomyolipoma) were immunohistochemically stained with parvalbumin. Overall, parvalbumin immunostain was found in fifty-six PEC lesions (85%) and absent in the remaining ten cases (15%). Classic angiomyolipomas were positive in almost all cases (97%). Intraglomerular lesions and AMLEC showed parvalbumin immunolabeling as well. None of the 7 epithelioid angiomyolipomas/pure epithelioid PEComas or the only sclerosing angiomyolipoma expressed parvalbumin. In conclusion, we demonstrated the immunolabeling of parvalbumin in almost all PEC lesions of the kidney, but not in the epithelioid angiomyolipoma/pure epithelioid PEComa. This finding could shed light on some biological characteristics observed in the PEC lesions such as the plasticity of their cellular component. Moreover, parvalbumin may be another useful tool in the differential diagnosis among epithelioid angiomyolipoma/pure epithelioid PEComa with other renal eosinophilic tumors, such as oncocytoma and chromophobe renal cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Celio MR, Heizmann CW (1981) Calcium-binding protein parvalbumin as a neuronal marker. Nature 293:300–302

    Article  CAS  Google Scholar 

  2. Olinger E, Schwaller B, Loffing J, Gailly P, Devuyst O (2012) Parvalbumin: calcium and magnesium buffering in the distal nephron. Nephrol Dial Transplant 27:3988–3994

    Article  CAS  Google Scholar 

  3. Martignoni G, Pea M, Chilosi M, Brunelli M, Scarpa A, Colato C, Tardanico R, Zamboni G, Bonetti F (2001) Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 14:760–767

    Article  CAS  Google Scholar 

  4. Brunelli M, Delahunt B, Gobbo S, Tardanico R, Eccher A, Bersani S, Cossu-Rocca P, Parolini C, Balzarini P, Menestrina F, Cheng L, Eble JN, Martignoni G (2010) Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. Am J Clin Pathol 133:116–126

    Article  Google Scholar 

  5. Martignoni G, Pea M, Brunelli M, Chilosi M, Zamo A, Bertaso M, Cossu-Rocca P, Eble JN, Mikuz G, Puppa G, Badoual C, Ficarra V, Novella G, Bonetti F (2004) CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod Pathol 17:1455–1463

    Article  CAS  Google Scholar 

  6. Zhou M, Roma A, Magi-Galluzzi C (2005) The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med 25:247–257

    Article  Google Scholar 

  7. Tickoo SK, de Peralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30:141–153

    Article  Google Scholar 

  8. Martignoni G, Brunelli M, Segala D, Munari E, Gobbo S, Cima L, Borze I, Wirtanen T, Sarhadi VK, Atanesyan L, Savola S, Barzon L, Masi G, Fassan M, Eble JN, Bohling T, Cheng L, Delahunt B, Knuutila S (2017) Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker. Pathology 49:10–18

    Article  CAS  Google Scholar 

  9. Caliò A, Brunelli M, Segala D, Pedron S, Remo A, Ammendola S, Munari E, Pierconti F, Mosca A, Bollito E, Sidoni A, Fisogni S, Sacco C, Canu L, Sentinelli S, Fraccon A, Fiorentino M, Scott C, Milella M, Porta C, Argani P, Martignoni G (2020) Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. Pathology 52:297–309

  10. Eble JN (1998) Angiomyolipoma of kidney. Semin Diagn Pathol 15:21–40

    CAS  PubMed  Google Scholar 

  11. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F (2008) PEComas: the past, the present and the future. Virchows Arch 452:119–132

    Article  Google Scholar 

  12. Martignoni G, Pea M, Zampini C, Brunelli M, Segala D, Zamboni G, Bonetti F (2015) PEComas of the kidney and of the genitourinary tract. Semin Diagn Pathol 32:140–159

    Article  Google Scholar 

  13. Fine SW, Reuter VE, Epstein JI, Argani P (2006) Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma. Am J Surg Pathol 30:593–599

    Article  Google Scholar 

  14. Ducreux S, Gregory P, Schwaller B (2012) Inverse regulation of the cytosolic Ca(2)(+) buffer parvalbumin and mitochondrial volume in muscle cells via SIRT1/PGC-1alpha axis. PLoS One 7:e44837

    Article  CAS  Google Scholar 

  15. Stone CH, Lee MW, Amin MB, Yaziji H, Gown AM, Ro JY, Tetu B, Paraf F, Zarbo RJ (2001) Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med 125:751–758

    Article  CAS  Google Scholar 

  16. Calio A, Warfel KA, Eble JN (2016) Pathological features and clinical associations of 58 small incidental angiomyolipomas of the kidney. Hum Pathol 58:41–46

    Article  CAS  Google Scholar 

  17. Martignoni G, Pea M, Rocca PC, Bonetti F (2003) Renal pathology in the tuberous sclerosis complex. Pathology 35:505–512

    Article  Google Scholar 

  18. Kilicaslan I, Gulluoglu MG, Dogan O, Uysal V (2000) Intraglomerular microlesions in renal angiomyolipoma. Hum Pathol 31:1325–1328

    Article  CAS  Google Scholar 

  19. Martignoni G, Bonetti F, Chilosi M, Brunelli M, Segala D, Amin MB, Argani P, Eble JN, Gobbo S, Pea M (2012) Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Mod Pathol 25:100–111

    Article  CAS  Google Scholar 

  20. Ebrahimi-Fakhari D, Saffari A, Wahlster L, Di Nardo A, Turner D, Lewis TL Jr, Conrad C, Rothberg JM, Lipton JO, Kolker S, Hoffmann GF, Han MJ, Polleux F, Sahin M (2016) Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex. Cell Rep 17:1053–1070

    Article  CAS  Google Scholar 

  21. Calio A, Brunelli M, Segala D, Pedron S, Tardanico R, Remo A, Gobbo S, Meneghelli E, Doglioni C, Hes O, Zampini C, Argani P, Martignoni G (2018) t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma. Mod Pathol 31:474–487

    Article  CAS  Google Scholar 

  22. Chilosi M, Pea M, Martignoni G, Brunelli M, Gobbo S, Poletti V, Bonetti F (2009) Cathepsin-k expression in pulmonary lymphangioleiomyomatosis. Mod Pathol 22:161–166

    Article  CAS  Google Scholar 

  23. Puertollano R, Ferguson SM, Brugarolas J, Ballabio A (2018) The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. EMBO J 37:e98804

Download references

Author information

Authors and Affiliations

Authors

Contributions

A Caliò and G. Martignoni: designed and coordinated the study. A. Caliò, S. Ammendola, G. Martignoni, M. Brunelli, and S.Gobbo: collected the samples. A. Caliò, S. Ammendola, G. Martignoni, M. Brunelli, S. Gobbo and S. Pedron: performed the histopathological and immunohistochemical analyses. A. Caliò, S. Ammendola, and G. Martignoni: wrote the paper. All the authors approved the final version of the manuscript.

Corresponding author

Correspondence to Guido Martignoni.

Ethics declarations

The study was conducted in accordance with the Helsinki Declaration.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Quality in Pathology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Caliò, A., Ammendola, S., Brunelli, M. et al. Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Virchows Arch 478, 785–791 (2021). https://doi.org/10.1007/s00428-020-02856-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-020-02856-y

Keywords

Navigation